{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T20:15:13Z","timestamp":1760645713853},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.bone.2009.09.024","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T05:28:19Z","timestamp":1254288499000},"page":"524-533","source":"Crossref","is-referenced-by-count":11,"title":["Osteolytic prostate cancer cells induce the expression of specific cytokines in bone-forming osteoblasts through a Stat3\/5-dependent mechanism"],"prefix":"10.1016","volume":"46","author":[{"given":"Jochen","family":"Schulze","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Albers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anke","family":"Baranowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Spiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Streichert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jozef","family":"Zustin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Amling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Schinke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2009.09.024_bb0005","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/nm1593","article-title":"Skeletal remodeling in health and disease","volume":"13","author":"Zaidi","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2009.09.024_bb0010","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/S0140-6736(06)68891-0","article-title":"Osteoporosis","volume":"367","author":"Sambrook","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2009.09.024_bb0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat. Rev."},{"key":"10.1016\/j.bone.2009.09.024_bb0020","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrc1528","article-title":"Osteoblasts in prostate cancer metastasis to bone","volume":"5","author":"Logothetis","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0025","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-1-4419-9129-4_13","article-title":"Histological, immunophenotypic and histomorphometric characterization of prostate cancer bone metastases","volume":"118","author":"Roudier","year":"2004","journal-title":"Cancer Treat. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0030","first-page":"2493","article-title":"Establishment of two human prostate cancer cell lines derived from a single bone metastasis","volume":"3","author":"Navone","year":"1997","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0035","first-page":"16","article-title":"Establishment and characterization of a human prostatic carcinoma cell line (PC-3)","volume":"17","author":"Kaighn","year":"1979","journal-title":"Invest. Urol."},{"key":"10.1016\/j.bone.2009.09.024_bb0040","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0092-8674(01)00571-2","article-title":"LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development","volume":"107","author":"Gong","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.bone.2009.09.024_bb0045","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bone.2009.09.024_bb0050","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/beta-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2009.09.024_bb0055","doi-asserted-by":"crossref","first-page":"7554","DOI":"10.1158\/0008-5472.CAN-05-1317","article-title":"Prostate cancer cells promote osteoblastic bone metastases through wnts","volume":"65","author":"Hall","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0060","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/sj.onc.1210694","article-title":"Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone","volume":"27","author":"Li","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bone.2009.09.024_bb0065","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/cncr.20518","article-title":"Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications","volume":"101","author":"Chen","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0070","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/bjc.1998.658","article-title":"Bone morphogenetic protein 6 in skeletal metastases from prostate cancer and other common human malignancies","volume":"78","author":"Autzen","year":"1998","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/pros.2990240406","article-title":"Expression of bone morphogenetic protein messenger RNAs by normal rat and human prostate and prostate cancer cells","volume":"24","author":"Harris","year":"1994","journal-title":"Prostate"},{"key":"10.1016\/j.bone.2009.09.024_bb0080","first-page":"2697","article-title":"Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms","volume":"118","author":"Li","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2009.09.024_bb0085","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm0995-944","article-title":"Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate","volume":"1","author":"Nelson","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2009.09.024_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1083\/jcb.200408013","article-title":"The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation","volume":"168","author":"Schmidt","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bone.2009.09.024_bb0095","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.20058","article-title":"MEK\/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor","volume":"50","author":"Lin","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2009.09.024_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/7445","article-title":"Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling","volume":"5","author":"Frank","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2009.09.024_bb0105","doi-asserted-by":"crossref","first-page":"12661","DOI":"10.1074\/jbc.275.17.12661","article-title":"Distinct mechanisms of STAT phosphorylation via the interferon-alpha\/beta receptor. Selective inhibition of STAT3 and STAT5 by piceatannol","volume":"275","author":"Su","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bone.2009.09.024_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1359\/jbmr.080907","article-title":"Paget's disease of bone: histologic analysis of 754 patients","volume":"24","author":"Seitz","year":"2009","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0115","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1359\/jbmr.060820","article-title":"Calcitonin deficiency in mice progressively results in high bone turnover","volume":"21","author":"Huebner","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0120","first-page":"2587","article-title":"Prostate cancer cells-osteoblast interaction shifts expression of growth\/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts","volume":"9","author":"Fizazi","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0125","first-page":"5652","article-title":"Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0130","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ng1603","article-title":"A deletion in the gene encoding sphingomyelin phosphodiesterase 3 (Smpd3) results in osteogenesis and dentinogenesis imperfecta in the mouse","volume":"37","author":"Aubin","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2009.09.024_bb0135","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1359\/jbmr.060311","article-title":"Deletion of a single allele of the Dkk1 gene leads to an increase in bone formation and bone mass","volume":"21","author":"Morvan","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0140","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1359\/jbmr.070108","article-title":"Functional involvement of PHOSPHO1 in matrix vesicle-mediated skeletal mineralization","volume":"22","author":"Roberts","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0145","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bone.2009.09.024_bb0150","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.bone.2007.11.009","article-title":"The protein tyrosine phosphatase Rptpzeta is expressed in differentiated osteoblasts and affects bone formation in mice","volume":"42","author":"Schinke","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.bone.2009.09.024_bb0155","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.cell.2006.05.012","article-title":"SATB2 is a multifunctional determinant of craniofacial patterning and osteoblast differentiation","volume":"125","author":"Dobreva","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bone.2009.09.024_bb0160","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrc1388","article-title":"Cancer and the chemokine network","volume":"4","author":"Balkwill","year":"2004","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0165","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1002\/ijc.22704","article-title":"PTHrP-induced MCP-1 production by human bone marrow endothelial cells and osteoblasts promotes osteoclast differentiation and prostate cancer cell proliferation and invasion in vitro","volume":"121","author":"Lu","year":"2007","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0170","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/en.2004-1167","article-title":"Cross-talk between the interleukin-6 and prostaglandin E(2) signaling systems results in enhancement of osteoclastogenesis through effects on the osteoprotegerin\/receptor activator of nuclear factor-{kappa}B (RANK) ligand\/RANK system","volume":"146","author":"Liu","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.bone.2009.09.024_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/16852","article-title":"OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis","volume":"397","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bone.2009.09.024_bb0180","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.canlet.2004.09.053","article-title":"Prostate cancer mediates osteoclastogenesis through two different pathways","volume":"223","author":"Inoue","year":"2005","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bone.2009.09.024_bb0185","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1128\/MCB.22.4.1172-1183.2002","article-title":"Wnt\/beta-catenin\/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway","volume":"22","author":"Jho","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bone.2009.09.024_bb0190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.modgep.2004.03.006","article-title":"Drapc1 expression during mouse embryonic development","volume":"4","author":"Jukkola","year":"2004","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.bone.2009.09.024_bb0195","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","article-title":"Cancer statistics, 1999","volume":"49","author":"Landis","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bone.2009.09.024_bb0200","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","author":"Bubendorf","year":"2000","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.bone.2009.09.024_bb0205","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1015599831232","article-title":"Prostate carcinoma skeletal metastases: cross-talk between tumor and bone","volume":"20","author":"Keller","year":"2001","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.bone.2009.09.024_bb0210","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G","article-title":"Skeletal complications of malignancy","volume":"80","author":"Coleman","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0215","doi-asserted-by":"crossref","first-page":"6213s","DOI":"10.1158\/1078-0432.CCR-06-1007","article-title":"Basic mechanisms responsible for osteolytic and osteoblastic bone metastases","volume":"12","author":"Guise","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0220","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z","article-title":"Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID\/bg mice using LNCaP and lineage-derived metastatic sublines","volume":"77","author":"Wu","year":"1998","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bone.2009.09.024_bb0225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pros.10091","article-title":"Establishment and characterization of osseous prostate cancer models: intra-tibial injection of human prostate cancer cells","volume":"52","author":"Corey","year":"2002","journal-title":"Prostate"},{"key":"10.1016\/j.bone.2009.09.024_bb0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/35077108","article-title":"LDL-receptor-related protein 6 is a receptor for Dickkopf proteins","volume":"411","author":"Mao","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bone.2009.09.024_bb0235","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Tian","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bone.2009.09.024_bb0240","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2141.1982.tb03936.x","article-title":"Quantitative histology of myeloma-induced bone changes","volume":"52","author":"Valentin-Opran","year":"1982","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bone.2009.09.024_bb0245","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/74999","article-title":"Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord","volume":"6","author":"Honore","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.bone.2009.09.024_bb0250","first-page":"1637","article-title":"Receptor activator of nuclear factor kappaB ligand (RANKL) is a key molecule of osteoclast formation for bone metastasis in a newly developed model of human neuroblastoma","volume":"61","author":"Michigami","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0255","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/jcb.10522","article-title":"Expression of CXCR4 and CXCL12 (SDF-1) in human prostate cancers (PCa) in vivo","volume":"89","author":"Sun","year":"2003","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bone.2009.09.024_bb0260","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/35065016","article-title":"Involvement of chemokine receptors in breast cancer metastasis","volume":"410","author":"M\u00fcller","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bone.2009.09.024_bb0265","first-page":"7328","article-title":"Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells","volume":"62","author":"Murakami","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0270","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1593\/neo.07976","article-title":"CXCL5 promotes prostate cancer progression","volume":"10","author":"Begley","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.bone.2009.09.024_bb0275","first-page":"961","article-title":"Induction of apoptosis by piceatannol in human leukemic U937 cells through down-regulation of Bcl-2 and activation of caspases","volume":"19","author":"Kim","year":"2008","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bone.2009.09.024_bb0280","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.phrs.2006.09.005","article-title":"Piceatannol attenuates lipopolysaccharide-induced NF-kappaB activation and NF-kappaB-related proinflammatory mediators in BV2 microglia","volume":"54","author":"Jin","year":"2006","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bone.2009.09.024_bb0285","doi-asserted-by":"crossref","unstructured":"Larrosa M, Tom\u00e1s-Barber\u00e1n FA, Esp\u00edn JC. The grape and wine polyphenol piceatannol is a potent inducer of apoptosis in human SK-Mel-28 melanoma cells. Eur J Nutr.;43:275-84.","DOI":"10.1007\/s00394-004-0471-5"},{"key":"10.1016\/j.bone.2009.09.024_bb0290","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2353\/ajpath.2008.071054","article-title":"Stat3 promotes metastatic progression of prostate cancer","volume":"172","author":"Abdulghani","year":"2008","journal-title":"Am. J. Pathol."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209019334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328209019334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T18:59:54Z","timestamp":1558551594000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328209019334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S8756328209019334"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2009.09.024","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}